Coeptis Therapeutics Holdings Inc (COEP)
$0.19
Performance
- $0.19$0.20$0.19
2.63%
Downside
Day's Volatility :7.04%
Upside
4.52%
- $0.17$1.38$0.19
8.42%
Downside
52 Weeks Volatility :87.39%
Upside
86.23%
Returns
| Period | Coeptis Therapeutics Holdings Inc | Index (Russel 2000) |
|---|---|---|
3 Months | -33.96% | 0.0% |
6 Months | -62.84% | 0.0% |
1 Year | -82.82% | 0.0% |
3 Years | -96.12% | -22.3% |
Highlights
Market Capitalization | 7.4M |
Book Value | - $0.01 |
Earnings Per Share (EPS) | -0.47 |
Wall Street Target Price | 3.0 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -187.35% |
Return On Equity TTM | -1481.29% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 1563.7% |
Gross Profit TTM | 75.0K |
EBITDA | -16.0M |
Diluted Eps TTM | -0.47 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -0.26 |
EPS Estimate Next Year | -0.17 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
Analyst Recommendation
- Current
- 1M Ago
- 3M Ago
Analyst Forecast
What analysts predicted
Upside of 1478.95%
Technicals Summary
Sell
Neutral
Buy
Coeptis Therapeutics Holdings Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Coeptis Therapeutics Holdings Inc | -9.64% | -62.84% | -82.82% | -96.12% | -96.12% |
 Regeneron Pharmaceuticals, Inc. | 5.97% | 16.25% | 37.11% | 69.18% | 305.56% |
 Novo Nordisk A/s | 9.99% | -3.52% | 34.24% | 158.74% | 417.73% |
 Alnylam Pharmaceuticals, Inc. | -5.15% | 64.67% | 22.72% | 31.08% | 198.44% |
 Vertex Pharmaceuticals Incorporated | 0.45% | 14.0% | 36.06% | 143.5% | 167.72% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Coeptis Therapeutics Holdings Inc | NA | NA | NA | -0.26 | -14.81 | -1.87 | NA | -0.01 |
Regeneron Pharmaceuticals, Inc. | 29.93 | 29.93 | 1.54 | 45.05 | 0.17 | 0.08 | NA | 261.41 |
Novo Nordisk A/s | 44.01 | 44.01 | 1.98 | 3.44 | 0.89 | 0.23 | 0.01 | 25.24 |
Alnylam Pharmaceuticals, Inc. | NA | NA | -0.49 | -2.55 | -15.01 | 0.02 | NA | -0.02 |
Vertex Pharmaceuticals Incorporated | 32.84 | NA | 0.57 | 0.32 | -0.03 | 0.13 | NA | 57.26 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Coeptis Therapeutics Holdings Inc | Buy | $7.4M | -96.12% | NA | 0.0% |
Regeneron Pharmaceuticals, Inc. | Buy | $124.7B | 305.56% | 29.93 | 32.04% |
Novo Nordisk A/s | Buy | $585.3B | 417.73% | 44.01 | 34.84% |
Alnylam Pharmaceuticals, Inc. | Buy | $32.3B | 198.44% | NA | -3.11% |
Vertex Pharmaceuticals Incorporated | Buy | $120.9B | 167.72% | 32.84 | -4.74% |
Insights on Coeptis Therapeutics Holdings Inc
Vs REGN
In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 37.1% return, outperforming this stock by 119.9%
Institutional Holdings
Creative Planning Inc
1.62%Meteora Capital, LLC
1.12%Geode Capital Management, LLC
0.48%Vanguard Group Inc
0.25%CAMBRIDGE Invest RESEARCH ADVISORS, INC.
0.14%Arista Wealth Management LLC
0.12%
Company Information
Organization | Coeptis Therapeutics Holdings Inc |
Employees | 5 |
CEO | Mr. David Mehalick |
Industry | Miscellaneous |
Discover More
A Spac I Acquisition Corp
$0.19
+0.27%
Keyarch Acquisition Corp
$0.19
+0.27%
Connexa Sports Technologies Inc
$0.19
+0.27%
Us Value Etf
$0.19
+0.27%
First Wave Biopharma Inc
$0.19
+0.27%
Global X Msci Next Emerging
$0.19
+0.27%
Fat Projects Acquisition Corp
$0.19
+0.27%
Capital Link Global Fintech
$0.19
+0.27%
Applied Uv Inc
$0.19
+0.27%